Methicillin-resistant Staphylococcus aureus (MRSA) causes difficult-to-treat nosocomial infections and is therefore a public health problem (8) . Resistance against methicillin and other ␤-lactam antibiotics is mediated by acquisition of an additional penicillin-binding protein, PBP2a or PBP2Ј, encoded by the mec determinant, which is present in resistant strains (21, 31, 34) . Because of its low affinity toward ␤-lactams, PBP2a seems to be able to take over the peptidoglycan-synthesizing function of the staphylococcal PBPs (PBP1 to 4) in the presence of otherwise lethal antibiotic concentrations (16) . However, the amount of PBP2a in the cell does not correlate with the phenotypically expressed resistance level (7, 9, 24) , suggesting that methicillin resistance is a complex phenomenon (4, 20, 27) , dependent on the genomic background of the strain in question.
By using transposon mutagenesis, mutants which are methicillin susceptible despite the expression of PBP2a have been isolated (6) . The inactivated genes in these mutants are not linked to the mec determinant and are called fem (factor essential for methicillin resistance) factors (5) or aux (auxiliary) genes (13) . In contrast to PBP2a, the fem factors are found in both resistant and susceptible S. aureus strains and are probably present in all staphylococci. Genes with high similarity to S. aureus fem factors have been described for S. haemolyticus (1) and S. epidermidis (2) .
The precise enzymatic function common to fem factors, if any, has not been determined, although most of them seem to be involved in peptidoglycan biosynthesis. Two of the known fem factors in S. aureus, FemA and FemB, are located in an operon and show a high degree of sequence homology to each other (5) . Inactivation of these genes causes, in addition to methicillin susceptibility, a reduced cell wall turnover (11, 25) and an impaired cell separation and shortening of the pentaglycine interpeptide (12, 17, 19, 22, 25, 30) , which is a characteristic component of the staphylococcal peptidoglycan. However, a direct function of the two proteins in the biosynthetic pathway of the glycine interpeptide bridge has not been demonstrated thus far, because of the lack of an enzymatic assay. FemAB null mutants become resistant to lysostaphin, an enzyme which degrades the staphylococcal peptidoglycan by cleavage within the glycine interpeptide bridge. This phenotype has been used for the selection of lysostaphin-resistant mutants upon chemical mutagenesis of the wild-type MRSA strain BB270 (NCTC8325 mec). The isolated mutants (UK14 to UK20) exhibited a femA-like phenotype, i.e., methicillin susceptibility, a reduced cell wall glycine content, and strong morphological aberrations during cell division and separation (19) . Moreover, the wild-type phenotype could be restored by introduction of femA into the mutants, suggesting that the mutations are located within the femA gene. We decided to sequence the femA region of each of these mutants to identify functional domains of femA. We found that femA mutants behave like femAB double mutants and that FemB is not able to substitute for FemA, as has been shown the other way round (17) . In addition, we determined the translational start of the native FemA protein.
Localization of the point mutations in the S. aureus mutants UK14 to UK20. The femA region of each of mutants UK14 to UK20 was amplified by PCR as described earlier (19) . The PCR products were separated by gel electrophoresis according to standard procedures (28) and purified with a High Pure PCR product purification kit (Boehringer, Mannheim, Germany). PCR products were sequenced by the enzymatic dideoxychain termination method (29) , using the direct blotting system from GATC (Konstanz, Germany). S. aureus mutants UK14 to UK20 were isolated by treatment of MRSA strain BB270 with the chemical mutagen ethyl methanesulfonate and selection for resistance against lysostaphin (19) . Ethyl methanesulfonate causes point mutations by the transition of G/C base pairs to A/T base pairs. To localize point mutations within the femA region of each of mutants UK14 to UK20, we sequenced both DNA strands of the femA genes and the promoter region of the femAB operon in all mutants with the sense primers SeqI to SeqV (5Ј-GTAATATGAGCAAACCCAAACG-3Ј, 5Ј-ATGA AAATTAACGAGAGAC-3Ј, 5Ј-GTCTATACCTACATATC GATCC-3Ј, 5Ј-GCTTTTGCTGATCGTGATGAC-3Ј, and 5Ј-GCCGGAAGTTATGCAGTGCAATGGG-3Ј) and the antisense primers SeqVI to SeqX (5Ј-CTTCAAAGCCATCATTC TCACGGG-3Ј, 5Ј-CCATAGAAATTATAACGGTCAATGC C-3Ј, 5Ј-CGCTAAAGGTACTAACACACGG-3Ј, 5Ј-CCAGC ATTACCTGTAATCTAGCC-3Ј, and 5Ј-CAGTTTGCGTGA AATGACTGTATGGC-3Ј).
As shown in Fig. 1 , all mutants carried point mutations in the femA region. With the exception of strain UK18, which contained the insertion of an additional base pair, all mutants showed the expected base pair exchange from G/C to A/T. Strain UK18 is probably a spontaneous mutant selected for growth in the presence of lysostaphin. Involvement of the FemA protein in biosynthesis of the staphylococcal glycine interpeptide bridge has been demonstrated earlier in various studies (12, 19, 22, 25, 30) . Attachment of the glycine residues is believed to take place at the level of the lipid precursor in the biosynthetic pathway of peptidoglycan (18, 26) . Because of the lack of an enzymatic assay, it is not yet clear whether FemA by itself catalyzes the attachment of the glycine residues or whether this protein contributes to the process in a yet unknown manner. In this regard, it is important to note that sequencing of the isolated mutants showed that all had point mutations in the femA region. We think that this is a first indication that indeed the femA protein itself catalyzes the addition of glycine residues to the growing pentaglycine bridge. Otherwise, one would expect to find mutants containing an intact femA gene but expressing a femA-like phenotype.
Based on the point mutations indicated in Fig. 1 , the following alterations in the amino acid sequence of FemA can be deduced. Mutants UK14, UK15, and UK16 were characterized by a point mutation near the N terminus of the protein, which caused the replacement of a glycine residue in position 10 by a glutamic acid residue, presuming that the protein is translated from the first of the three in-frame start codons as originally supposed by Berger-Bächi et al. (5) (Fig. 1) . Since glycine is rarely found as an amino acid important for the catalytic activity in the active site of an enzyme, it seemed unlikely that loss of a glycine residue close to the N terminus of FemA leads to its complete inactivation. Further inspection of the nucleotide sequence containing this point mutation revealed a high similarity to the Shine-Dalgarno consensus sequence AGGA GGT functioning as a ribosome binding site in all bacteria. Moreover, two of the three possible start codons were found a few base pairs downstream in the correct distance to the nucleotide sequence, which could function as a ribosome binding cassette (Fig. 1) . Therefore, we assumed that the point mutations found in UK14 to UK16 were located in the ribosome binding site, interfering with the translation initiation process. This could explain the absence of FemA in these strains. To prove this assumption, we determined the N-terminal amino acid sequence of FemA after its partial purification from strain BB586 (NCTC8325 mec⍀2003femAB::Tn551) carrying the femA-expressing plasmid pBBB31 (5). Bacteria were grown in brain heart infusion medium (Difco) containing 25 mg of chloramphenicol per liter at 37°C. Cells (500 ml) were harvested at an optical density at 600 nm of 0.7 and washed with 0.1 M Tris Cl (pH 8.0). The pellet was resuspended in 3 ml of buffer containing 5 g of lysostaphin (Sigma) per ml and 0.1 M NaCl. Cells were incubated at 37°C for 20 min with agitation before grinding with 10 g of alumina at Ϫ20°C. The suspension was centrifuged for 10 min at 10,000 ϫ g. The resulting supernatant containing the crude extract (50 g) was separated by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis (23) and transferred onto a 0.45-m-pore-size polyvinylidene difluoride membrane (Immobilon-P; Millipore) by Western blotting (33) . Proteins were stained with Coomassie blue, and FemA was identified by comparison with the crude extract from the femAB deletion mutant AS145 (NCTC8325 mec ⌬femAB::tetK) (30) . N-terminal sequencing was performed by using a protein sequencer (model 473A; Applied Biosystems, Foster City, Calif.) with standard Edman chemistry. The Nterminal sequence for the native FemA protein in S. aureus was Met-Lys-Phe-Thr-Asn-Leu-Thr-Ala-Lys-Glu-Phe-Gly-AlaPhe-Thr. Based on this result, we conclude that the third inframe start codon is used as the translational start site in S. aureus and that mutants UK14 to UK16 are mutated in the noncoding region of femA, probably within the ribosome binding site. The N-terminal sequence analysis showed that the native FemA protein contained 420 amino acids instead of 433 as been described earlier (5) .
The point mutations found in strains UK17, UK19, and UK20 resulted in stop codons and therefore in the expression of truncated proteins. In strain UK17, the glutamine residue 294 (CAA) was converted into the ochre stop codon TAA. In mutants UK19 and UK20, the tryptophan residue 130 (TGG) was replaced by the stop TGA (opal). Mutant strain UK20 contained in addition to the stop codon a second point mutation, which replaces the glutamic acid residue in position 31 by a lysine. The insertion of one base pair in strain UK18 caused a frameshift and a stop codon a few nucleotides downstream of the frameshift, also leading to the expression of a truncated FemA protein.
Since all of the mutants carrying point mutations within the coding region of femA (UK17 to UK20) expressed truncated proteins, it was not possible to identify any amino acid important for the enzymatic activity of FemA. It is not clear whether the Glu31Lys replacement in strain UK20 led to the inactivation of the protein, because this strain carried in addition the stop codon which was also found in strain UK19. Sequence comparison of femA with femB from S. aureus (GenBank accession no. M23918) or with femA genes from different staphylococci (GenBank accession no. U23713) shows that Glu31 is not a conserved amino acid. Thus, it seems rather unlikely that Glu31 is important for the function of FemA.
The mutation present in strain UK18 caused the loss of the last 35 amino acids at the C terminus of the protein. Since FemA is also completely inactive in this mutant, one can assume that the C-terminal domain of the protein is crucial for its function. Interestingly, the C terminus is the region differing most between the sequences of FemA and FemB in S. aureus. These findings indicate that the active site of the protein or an important substrate binding site is probably located near the C terminus.
Peptidoglycan composition of femA and femAB mutants. Recently, it has been shown that inactivation of femB leads to a shortening of the staphylococcal pentaglycine interpeptide bridge from five to three glycine residues (17) . Upon inactivation of femAB, the pentaglycine bridge was reduced to only one glycine residue (30) . Based on these results, it has been concluded that FemA is involved in the addition of glycine residues 2 and 3, whereas FemB functions in the attachment of glycine residues 4 and 5, respectively. A hypothetical protein FemX has been postulated for the addition of the first glycine residue in the pentaglycine interpeptide bridge (19, 22) .
The peptidoglycan composition of the femA mutants UK14 to UK20 has been analyzed before (19) . All mutants contained only muropeptides modified by monoglycine residues (19) , confirming the absence of a functional FemA protein. It is important to note that the femA mutants UK14 to UK20 showed the same muropeptide pattern as has been analyzed for the femAB double mutant AS145 containing the tetracycline resistance determinant tetK within the femAB operon (30) . Strain AS145 has also been generated from the parent strain BB270. Upon complementation of mutant strains UK14 to UK20 with the femA-carrying plasmid pBBB31, generating strains UK14A to UK20A, the wild-type muropeptide profile with pentaglycine residues was restored (19) . However, upon complementation of the femAB double mutant with this plasmid, resulting in strain AS164, a completely different muropeptide pattern has been obtained (30) . In contrast to the mutants UK14 to UK20, the wild-type muropeptide pattern could not be restored. The dominating muropeptide species contained triglycine residues, whereas no pentaglycine residues could be found. As expected, complementation of the femAB double mutant AS145 with the plasmid-encoded femA restored only the FemA function, i.e., attachment of glycine residues 2 and 3. Therefore, we have to conclude that mutants UK14 to UK20 contain an inactivated femA gene, as verified by the sequencing results, but in contrast to strain AS145 have an intact femB gene. Upon introduction of plasmid pBBB31 into the mutant strains UK14 to UK20, glycine residues 2 and 3 are attached by the plasmid-encoded FemA protein, whereas glycine residues 4 and 5 are attached by the chromosomal FemB protein. Thus, the point mutations located in femA have no polar effect on the downstream-located femB. The femA mutants UK14 to UK20 expressed the same phenotype as the femAB double mutant AS145. In both cases, only muropeptides with monoglycine residues were found. The data suggest that the intact FemB protein present in strains UK14 to UK20 is not able to take over the function of FemA. It seems that FemA is absolutely essential for the addition of glycines 2 and 3 but cannot add glycines 4 and 5, because femB mutants contained only three glycine residues (17) . Attachment of glycine residues 4 and 5 to the triglycine bridge synthesized by the hypothetical FemX and FemA requires the function of FemB. Although FemA and FemB show a relatively high sequence similarity to each other (39% identity in amino acid sequence), their enzymatic function seems to be highly specific with regard to the glycine residues. It may be that the two proteins interact with each other in a complex during synthesis of the glycine bridge. It will therefore be interesting to compare the three-dimensional structures of FemA and FemB and to investigate, e.g., by affinity chromatography, whether they are able to form complexes. However, it will be even more important to prove the enzymatic function of FemA and FemB in an enzymatic assay.
The glycine interpeptide bridge is synthesized at the membrane-bound murein lipid precursor (lipid II) facing the cytoplasm of the cell (18, 26) . In addition to the mono-, tri-, and pentaglycine bridges present in the cell wall, the existence of lipid intermediates containing two and four glycine residues has been described (26, 32) . Based on these results, a stepwise addition of the glycine residues has been proposed. The first glycine is attached to the ε-amino group of the lysine present in the stem peptide. The other glycine residues are then added one by one to the N terminus of the growing side chain. Glycyl-tRNA serves as a substrate in this process. Beside the glycyl-tRNA used in protein synthesis, three additional tRNA molecules charged with glycine have been found in S. aureus (14) . The latter species of tRNA seem to be used exclusively for cell wall biosynthesis. One could speculate that each Fem factor uses one of the three glycyl-tRNA molecules involved in cell wall synthesis as a substrate. Up to now, no glycyl-glycine intermediates have been found in S. aureus. Taken together, the data suggest that glycine residues 2 to 5 are attached as single amino acids catalyzed by the two FemAB proteins.
It is still not known why S. aureus uses two nearly identical but highly specific proteins for the addition of four glycine residues, which are attached by exactly the same enzymatic reaction. A high concentration of free glycine in the medium reduces the growth rate of S. aureus (15) , and glycine instead of alanine is incorporated into the stem peptide (10) . Mutants in femAB exhibit also a reduced growth rate, which might partly be due to the higher amount of free glycine not used in cell wall biosynthesis. However, we could not detect a greatly enlarged muropeptide fraction containing glycine in the stem peptide. Nevertheless, it might be important for the cell to coordinate the distribution of glycine between protein and cell wall synthesis and to keep the amount of free glycine within a narrow range. This could be ensured by the existence of different proteins with high specificity and different glycyl-tRNA molecules.
